Nucleoside analogue activators of cyclic AMP-independent protein kinase A of Trypanosoma
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2041-1723
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Nucleoside analogue activators of cyclic AMP-independent protein kinase A of Trypanosoma ; volume:10 ; number:1 ; day:29 ; month:3 ; year:2019 ; pages:1-14 ; date:12.2019
Nature Communications ; 10, Heft 1 (29.3.2019), 1-14, 12.2019
- Klassifikation
-
Naturwissenschaften
- Urheber
-
Bachmaier, Sabine
Volpato Santos, Yuri
Kramer, Susanne
Githure, George Boniface
Klöckner, Thomas
Pepperl, Julia
Baums, Cordula
Schenk, Robin
Schwede, Frank
Genieser, Hans-Gottfried
Dupuy, Jean-William
Forné, Ignasi
Imhof, Axel
Basquin, Jerôme
Lorentzen, Esben
Boshart, Michael
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41467-019-09338-z
- URN
-
urn:nbn:de:101:1-2019041621323201147349
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:51 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Bachmaier, Sabine
- Volpato Santos, Yuri
- Kramer, Susanne
- Githure, George Boniface
- Klöckner, Thomas
- Pepperl, Julia
- Baums, Cordula
- Schenk, Robin
- Schwede, Frank
- Genieser, Hans-Gottfried
- Dupuy, Jean-William
- Forné, Ignasi
- Imhof, Axel
- Basquin, Jerôme
- Lorentzen, Esben
- Boshart, Michael
- SpringerLink (Online service)
Ähnliche Objekte (12)
Interferon-Free Strategies with a Nucleoside/Nucleotide Analogue
Interferon-Free Strategies without a Nucleoside/Nucleotide Analogue
Differences between intrinsic and acquired nucleoside analogue resistance in acute myeloid leukaemia cells
Differences between intrinsic and acquired nucleoside analogue resistance in acute myeloid leukaemia cells
Nucleoside analogue 2’-C-methylcytidine inhibits hepatitis E virus replication but antagonizes ribavirin
AMP ed up to treat prostate cancer: novel AMPK activators emerge for cancer therapy
Tenofovir rescue therapy in chronic hepatitis B patients who failed previous nucleoside analogue treatment
Nucleoside diphosphate kinase A as a controller of AMP-kinase in airway epithelia
Treatment with Cyclic AMP Activators Reduces Glioblastoma Growth and Invasion as Assessed by Two-Photon Microscopy
Uridine supplementation with Mitocnol antagonizes antiretroviral nucleoside analogue-induced mitochondrial peripheral and cerebral neuropathy in vivo
An enantioselective and modular platform for C4ʹ-modified nucleoside analogue synthesis enabled by intramolecular trans-acetalizations
The esogetic crystal activators
Interferon-Free Strategies with a Nucleoside/Nucleotide Analogue
Interferon-Free Strategies without a Nucleoside/Nucleotide Analogue
Differences between intrinsic and acquired nucleoside analogue resistance in acute myeloid leukaemia cells
Differences between intrinsic and acquired nucleoside analogue resistance in acute myeloid leukaemia cells
Nucleoside analogue 2’-C-methylcytidine inhibits hepatitis E virus replication but antagonizes ribavirin
AMP ed up to treat prostate cancer: novel AMPK activators emerge for cancer therapy
Tenofovir rescue therapy in chronic hepatitis B patients who failed previous nucleoside analogue treatment
Nucleoside diphosphate kinase A as a controller of AMP-kinase in airway epithelia
Treatment with Cyclic AMP Activators Reduces Glioblastoma Growth and Invasion as Assessed by Two-Photon Microscopy
Uridine supplementation with Mitocnol antagonizes antiretroviral nucleoside analogue-induced mitochondrial peripheral and cerebral neuropathy in vivo
An enantioselective and modular platform for C4ʹ-modified nucleoside analogue synthesis enabled by intramolecular trans-acetalizations
The esogetic crystal activators
Interferon-Free Strategies with a Nucleoside/Nucleotide Analogue
Interferon-Free Strategies without a Nucleoside/Nucleotide Analogue
Differences between intrinsic and acquired nucleoside analogue resistance in acute myeloid leukaemia cells
Differences between intrinsic and acquired nucleoside analogue resistance in acute myeloid leukaemia cells
Nucleoside analogue 2’-C-methylcytidine inhibits hepatitis E virus replication but antagonizes ribavirin
AMP ed up to treat prostate cancer: novel AMPK activators emerge for cancer therapy
Tenofovir rescue therapy in chronic hepatitis B patients who failed previous nucleoside analogue treatment
Nucleoside diphosphate kinase A as a controller of AMP-kinase in airway epithelia
Treatment with Cyclic AMP Activators Reduces Glioblastoma Growth and Invasion as Assessed by Two-Photon Microscopy
Uridine supplementation with Mitocnol antagonizes antiretroviral nucleoside analogue-induced mitochondrial peripheral and cerebral neuropathy in vivo
An enantioselective and modular platform for C4ʹ-modified nucleoside analogue synthesis enabled by intramolecular trans-acetalizations